New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and p53 activation in neurodegenerative diseases.

Continue Reading

News Source: medicalxpress.com